MedAI Verdict

AI Radiology · 58 tools

Editorial illustration: a chest radiograph alongside a magnifying glass highlighting flagged regions in blue.

Optellum Virtual Nodule Clinic

Optellum Virtual Nodule Clinic logo
35/ 100

Evidence & Documentation Score

This legacy score reflects documented evidence, integrations, transparency, and market signals. It does not measure overall product performance. A new product-focused rating system is in development. How it is computed

reviewed November 2, 2026

Vendor
Optellum, GB
Pricing
No public price. Reimbursement fact, not a price: CPT Category III codes 0721T and +0722T; Medicare hospital outpatient APC 1508 rate $650.50 for 2026 (national average, before deductibles).
EHR
Not stated
Compliance
FDA 510(k), CE, ISO 13485:2016 +1 more

Bottom line. Optellum Virtual Nodule Clinic is CT software that tracks incidentally found lung nodules, prioritizes the patients and returns a cancer-risk score for each nodule. Its 510(k) from March 2021 makes the scoring function available only to pulmonologists and radiologists. Pulmonology programs and radiology departments that run nodule follow-up are the buyers. Reimbursement runs through two CPT codes, 0721T and +0722T.

Visit Optellum Virtual Nodule Clinic (opens in new tab)

FDA 510(k) · CE · ISO 13485:2016 · ISO/IEC 27001

Performance profile

  • Regulatory and compliance18 / 28
  • Clinical integration0 / 6.6
  • Evidence strength0 / 26
  • Vendor and market9 / 18
  • Sentiment and transparency2.5 / 5

Performance profile

  • Regulatory and compliance18 / 28
  • Clinical integration0 / 6.6
  • Evidence strength0 / 26
  • Vendor and market9 / 18
  • Sentiment and transparency2.5 / 5
On this page

All 9 dimensions

Regulatory and compliance

  • FDA clearance18 / 18

    FDA cleared (1 510(k) clearance on record)

  • HIPAA / SOC2 / BAA0 / 10

    No public HIPAA/SOC2/BAA attestation

Clinical integration

  • EHR integrations (count)0 / 4.2

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.4

    None of the top-3 EHRs covered

Evidence strength

  • Peer-reviewed papers0 / 18.2

    No peer-reviewed paper evaluating the product

  • RCT / meta-analysis / systematic review0 / 7.8

    No RCT, meta-analysis, or systematic review evaluating the product

Vendor and market

  • Funding & adoption signal3 / 12

    Seed-stage or unfunded

  • Years in market6 / 6

    Founded 2016 (10 years)

Sentiment and transparency

  • Pricing transparency2.5 / 5

    Pricing on request, no public amounts

Computed November 6, 2026 by our public rubric. How it’s computed

What it costs

From
No public price. Reimbursement fact, not a price: CPT Category III codes 0721T and +0722T; Medicare hospital outpatient APC 1508 rate $650.50 for 2026 (national average, before deductibles).
Price points
1
Verified
November 2, 2026
Source
Vendor pricing page

All tiers are custom-quoted. The vendor does not publish per-provider list pricing.

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. Reimbursement fact, not a price: CPT Category III codes 0721T and +0722T; Medicare hospital outpatient APC 1508 rate $650.50 for 2026 (national average, before deductibles).

Source: vendor pricing page. Last checked November 2, 2026.

Compliance

Attested
FDA 510(k), CE, ISO 13485:2016, ISO/IEC 27001
EHR integrations
Not stated
FDA
1 decision on record

Carries FDA 510(k), CE, ISO 13485:2016, ISO/IEC 27001 per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.

Vendor stability

Company
Optellum
Headquarters
GB
Founded
2016

Optellum Virtual Nodule Clinic (Optellum) was founded in 2016 in GB, putting it 10 years into market.

Vendor sitewww.optellum.com (opens in new tab)

Evidence record

RecordWhat we found
FDA decisions
Verification
  • Score computed November 6, 2026, method 1.2.1
  • Review written November 2, 2026
Cite this record

MedAI Verdict, Optellum Virtual Nodule Clinic record, https://medaiverdict.com/tools/optellum, version November 2, 2026

Change historyView every change to this record

Bottom line

FDA-cleared AI that scores lung cancer risk for CT lung nodules and tracks them, for pulmonologists and radiology departments.

No public price. Reimbursement fact, not a price: CPT Category III codes 0721T and +0722T; Medicare hospital outpatient APC 1508 rate $650.50 for 2026 (national average, before deductibles).

What does the risk score rest on?

The 510(k) text describes an algorithm that "calculates a single value, the LCP-CNN score" using only imaging features from the CT, shown against a database of cases with known ground truth. The cleared scope is tracking, assessment and characterization of incidentally detected pulmonary nodules on lung CT. openFDA lists one Optellum 510(k), K202300, dated March 5, 2021. The vendor's timeline shows a zero-click version of the prediction AI as ready for clearance in 2024.

Optellum calls its offering "the world's only FDA-cleared and UKCA / CE-marked reimbursable radiomics AI solution for lung cancer diagnosis." It also markets Lung Cancer Prediction AI and a Patient Discovery AI module for prioritization.

Who sells it?

Optellum was founded in 2016 and runs offices in Oxford, England and Houston, Texas. Its Trust Centre lists ISO 13485:2016 and ISO/IEC 27001. The vendor says LCP AI is integrated with RapidAI's Rapid Enterprise platform and that SimonMed built it into its workflow.

What do the papers cover?

A 2020 Thorax paper (PMID 32139611) is an external validation of a CNN tool to predict malignancy in pulmonary nodules. A 2023 Chest paper (PMID 36087795) compares CNN assessment of solitary pulmonary nodules with PET-CT and dynamic contrast-enhanced CT. A 2023 JAMA Network Open paper (PMID 36929398) recalibrates a deep learning model for low-dose CT to inform screening intervals. Several papers on the tool are model papers from the developer, and developer affiliation is unknown for each of these three.

The vendor states more than 71% more interventional procedures and more than 50% shorter time to diagnosis, and labels the sources as in preparation or internal data.

What does reimbursement look like?

No public price, though payment facts exist. The reimbursement page lists CPT code 0721T for CT tissue characterization without concurrent CT and add-on code +0722T for use with concurrent CT, effective July 1, 2022, both in Category III. The Medicare hospital outpatient rate under APC 1508, status indicator S, is $650.50 for 2026 (national average, before deductibles). Physician payment is carrier-priced and commercial payment varies.

The verdict

A nodule clinic that wants scoring and tracking for incidental findings, and a billing route for them, is the match, with the 2026 Medicare outpatient rate of $650.50 as the one national figure attached.

Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

Link to this review

Optellum Virtual Nodule Clinic, reviewed on MedAI Verdict

Vendors may place this badge on their own site. It links to this review with a tracking parameter and has no effect on the score.

<a href="https://medaiverdict.com/tools/optellum?utm_source=vendor_badge&utm_medium=badge&utm_campaign=optellum"><img src="https://medaiverdict.com/badges/reviewed-on-medaiverdict.png" srcset="https://medaiverdict.com/badges/reviewed-on-medaiverdict@2x.png 2x" alt="Optellum Virtual Nodule Clinic, reviewed on MedAI Verdict" width="200" height="56"></a>

What we have not verified

  1. We have not run Optellum Virtual Nodule Clinic in our own clinical practice. Pricing, certifications, and EHR-integration claims come from vendor documentation and have not been independently audited.
  2. Enterprise pricing tiers and SLA terms are typically under NDA and not publicly verifiable. Numbers shown reflect publicly disclosed self-service or list pricing only.
  3. Real-world latency, note quality, and accuracy in your specific specialty and patient population can vary materially from vendor demonstrations. We recommend a 30-day trial with two providers before commitment.

Last verified . Read our methodology · Radiology